Current and historical daily PE Ratio for Repligen Corp (
) from 1990 to May 21 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Repligen stock (RGEN) PE ratio as of May 21 2024 is 687.12.
More Details
Repligen Corp (RGEN) PE Ratio (TTM) Chart
Repligen Corp (RGEN) PE Ratio (TTM) Historical Data
View and export this data going back to 1990. Start your Free Trial
Total 1237
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Repligen PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-21 | 687.1 | 2024-03-19 | 276.0 |
| 2024-05-20 | 687.1 | 2024-03-18 | 269.8 |
| 2024-05-17 | 687.8 | 2024-03-15 | 263.8 |
| 2024-05-16 | 684.1 | 2024-03-14 | 268.9 |
| 2024-05-15 | 704.1 | 2024-03-13 | 270.0 |
| 2024-05-14 | 689.9 | 2024-03-12 | 267.7 |
| 2024-05-13 | 653.4 | 2024-03-11 | 268.3 |
| 2024-05-10 | 667.2 | 2024-03-08 | 271.5 |
| 2024-05-09 | 659.6 | 2024-03-07 | 275.6 |
| 2024-05-08 | 662.0 | 2024-03-06 | 271.0 |
| 2024-05-07 | 670.9 | 2024-03-05 | 266.8 |
| 2024-05-06 | 672.2 | 2024-03-04 | 271.8 |
| 2024-05-03 | 668.2 | 2024-03-01 | 271.6 |
| 2024-05-02 | 665.2 | 2024-02-29 | 269.4 |
| 2024-05-01 | 633.4 | 2024-02-28 | 272.1 |
| 2024-04-30 | 656.8 | 2024-02-27 | 267.6 |
| 2024-04-29 | 664.6 | 2024-02-26 | 266.4 |
| 2024-04-26 | 666.3 | 2024-02-23 | 272.9 |
| 2024-04-25 | 662.6 | 2024-02-22 | 268.6 |
| 2024-04-24 | 671.4 | 2024-02-21 | 269.6 |
| 2024-04-23 | 685.1 | 2024-02-20 | 277.4 |
| 2024-04-22 | 629.9 | 2024-02-19 | 289.5 |
| 2024-04-19 | 628.6 | 2024-02-16 | 289.5 |
| 2024-04-18 | 628.2 | 2024-02-15 | 286.1 |
| 2024-04-17 | 643.9 | 2024-02-14 | 286.2 |
| 2024-04-16 | 656.7 | 2024-02-13 | 275.6 |
| 2024-04-15 | 665.6 | 2024-02-12 | 285.7 |
| 2024-04-12 | 686.1 | 2024-02-09 | 284.7 |
| 2024-04-11 | 704.3 | 2024-02-08 | 283.3 |
| 2024-04-10 | 704.0 | 2024-02-07 | 280.2 |
| 2024-04-09 | 727.7 | 2024-02-06 | 278.5 |
| 2024-04-08 | 696.2 | 2024-02-05 | 272.4 |
| 2024-04-05 | 695.2 | 2024-02-02 | 272.5 |
| 2024-04-04 | 691.8 | 2024-02-01 | 267.6 |
| 2024-04-03 | 709.3 | 2024-01-31 | 263.1 |
| 2024-04-02 | 711.7 | 2024-01-30 | 268.7 |
| 2024-04-01 | 731.8 | 2024-01-29 | 267.0 |
| 2024-03-29 | 735.7 | 2024-01-26 | 268.6 |
| 2024-03-28 | 735.7 | 2024-01-25 | 257.6 |
| 2024-03-27 | 256.6 | 2024-01-24 | 252.4 |
| 2024-03-26 | 255.3 | 2024-01-23 | 259.8 |
| 2024-03-25 | 256.8 | 2024-01-22 | 255.9 |
| 2024-03-22 | 275.0 | 2024-01-19 | 247.3 |
| 2024-03-21 | 277.4 | 2024-01-18 | 241.9 |
| 2024-03-20 | 273.2 | 2024-01-17 | 237.2 |
Repligen Corp (RGEN) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Repligen Corp
NAICS : 339112
SIC : 3841
ISIN : US7599161095
Share Class Description:
RGEN: Ordinary SharesDescription
Repligen Corp is a global life sciences company. It develops and commercializes innovative bioprocessing technologies and systems that increase efficiencies and flexibility in the process of manufacturing biological drugs. The company's customers include life science companies, global biopharmaceutical companies, and contract manufacturers worldwide. Repligen markets its products globally through a direct commercial organization in the U.S., Europe, and Asia, as well as through strategic partners in select markets. The majority of the company's revenue is generated in North America.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers